MediPharm Labs Corp. (MEDIF)
OTCMKTS · Delayed Price · Currency is USD
0.0562
+0.0012 (2.18%)
Aug 22, 2025, 3:54 PM EDT
MediPharm Labs Market Cap
MediPharm Labs has a market cap or net worth of $22.81 million as of August 22, 2025. Its market cap has increased by 8.97% in one year.
Market Cap
22.81M
Enterprise Value
15.51M
Revenue
32.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since October 5, 2018, MediPharm Labs's market cap has decreased from 164.72M to 22.81M, a decrease of -86.15%. That is a compound annual growth rate of -24.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 22.81M | 33.06% |
| Dec 31, 2024 | 17.14M | -13.20% |
| Dec 29, 2023 | 19.75M | 35.34% |
| Dec 30, 2022 | 14.59M | -63.10% |
| Dec 31, 2021 | 39.55M | -38.87% |
| Dec 31, 2020 | 64.70M | -83.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 633.65M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 594.33M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 368.43M |